Solid Biosciences, Inc. (SLDB)
10.08
+0.36
(+3.70%)
USD |
NASDAQ |
Aug 27, 12:30
Solid Biosciences Debt to Equity Ratio : 0.0539 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0539 |
| March 31, 2026 | 0.0552 |
| December 31, 2025 | 0.1176 |
| September 30, 2025 | 0.1007 |
| June 30, 2025 | 0.0892 |
| March 31, 2025 | 0.0802 |
| December 31, 2024 | 0.1762 |
| September 30, 2024 | 0.148 |
| June 30, 2024 | 0.1309 |
| March 31, 2024 | 0.1225 |
| December 31, 2023 | 0.2077 |
| September 30, 2023 | 0.1859 |
| June 30, 2023 | 0.1673 |
| March 31, 2023 | 0.1511 |
| December 31, 2022 | 0.1349 |
| September 30, 2022 | 0.1793 |
| June 30, 2022 | 0.154 |
| March 31, 2022 | 0.0082 |
| December 31, 2021 | 0.0099 |
| September 30, 2021 | 0.0102 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.0117 |
| March 31, 2021 | 0.0183 |
| December 31, 2020 | 0.039 |
| September 30, 2020 | 0.2543 |
| June 30, 2020 | 0.1509 |
| March 31, 2020 | 0.1172 |
| December 31, 2019 | 0.0883 |
| September 30, 2019 | 0.0691 |
| June 30, 2019 | 0.1036 |
| March 31, 2019 | 0.0808 |
| December 31, 2018 | 0.0082 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
| BioCryst Pharmaceuticals, Inc. | -1.842 |
| Imunon, Inc. | 1.873 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 420.58M |
| Total Liabilities (Quarterly) | 46.50M |
| Shareholders Equity (Quarterly) | 374.08M |
| Current Ratio | 13.82 |
| Net Debt Paydown Yield | 0.07% |